Abstract
Purpose
This narrative review seeks to investigate intraocular pressure (IOP), glaucoma medication dependence and safety profile of canaloplasty performed via an ab-interno surgical technique using the iTrack canaloplasty microcatheter (Nova Eye Medical).
Methods
A literature search was performed in March 2022 using MEDLINE and EMBASE to identify all papers which performed ab-interno canaloplasty using the iTrack, either combined with phacoemulsification or as a standalone procedure in primary open angle glaucoma. IOP was the primary efficacy outcome. Secondary outcomes were glaucoma medication use and safety profile.
Results
The search demonstrated 170 results of which 9 studies were included which totaled 365 eyes. Both IOP and number of medications were reduced at 12–24 months. IOP decreased from 20.0 ± 2.5 mmHg preoperatively to 13.8 ± 0.6 and at 14.0 ± 0.9 at 12 and 24 months; the number of medications was reduced from 2.5 ± 0.5 preoperatively to 0.8 ± 0.4 and 0.9 ± 0.6 at 12 and 24 months postoperatively. Comparable results were observed in the iTrack-alone and iTrack + phaco groups: IOP was reduced from baseline 20.5 ± 1.9 and 19.6 ± 3.0 to 14.3 ± 1.1 and 13.9 ± 1.1 24 months postoperatively respectively.
Conclusion
This review suggests that ab-interno canaloplasty as a standalone procedure or combined with phacoemulsification using the iTrack leads to a reduction in IOP and glaucoma medication use up to 24 months postoperatively.
Similar content being viewed by others
References
Quigley HA (2006) The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 90:262–267. https://doi.org/10.1136/bjo.2005.081224
Tham Y-CC, Li X, Wong TY et al (2014) Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology 121:2081–2090. https://doi.org/10.1016/j.ophtha.2014.05.013
Heijl A, Leske MC, Bengtsson B et al (2002) Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial. Arch Ophthalmol 120:1268–1279. https://doi.org/10.1001/archopht.120.10.1268
Prum BE, Rosenberg LF, Gedde SJ et al (2016) Primary open-angle glaucoma preferred practice pattern® guidelines. Ophthalmology 123:P41–P111. https://doi.org/10.1016/j.ophtha.2015.10.053
Kaur D, Gupta A, Singh G (2012) Perspectives on quality of life in glaucoma. J Curr Glaucoma Pract 6:9–12. https://doi.org/10.5005/jp-journals-10008-1101
Zhang X, Vadoothker S, Munir WM, Saeedi O (2019) Ocular surface disease and glaucoma medications: a clinical approach. Eye Contact Lens 45:11–18. https://doi.org/10.1097/ICL.0000000000000544
Inoue K (2014) Managing adverse effects of glaucoma medications. Clin Ophthalmol 8:903–913. https://doi.org/10.2147/OPTH.S44708
Vijaya L, Manish P, Ronnie G, Shantha B (2011) Management of complications in glaucoma surgery. Indian J Ophthalmol 59(Suppl):S131–S140. https://doi.org/10.4103/0301-4738.73689
Popovic M, Campos-Moller X, Saheb H, Ahmed IIK (2018) Efficacy and adverse event profile of the iStent and iStent inject trabecular micro-bypass for open-angle glaucoma: a meta-analysis. J Curr Glaucoma Pract 12:67–84. https://doi.org/10.5005/jp-journals-10008-1248
The Royal College of Ophthalmologists College advice on withdrawal of CyPass Micro-Stent by Alcon. Accessed 12 Sep 2021
Nichani P, Popovic MM, Schlenker MB et al (2021) Microinvasive glaucoma surgery: a review of 3476 eyes. Surv Ophthalmol 66:714–742. https://doi.org/10.1016/j.survophthal.2020.09.005
Rezkallah A (2019) XEN gel stent a total delayed-onset postoperative hyphema. Int J Ophthalmol 12:1224–1226. https://doi.org/10.18240/ijo.2019.07.27
Sunderland DK, Sapra A (2020) Physiology, Aqueous Humor Circulation. StatPearls
Tektas O-Y, Lütjen-Drecoll E (2009) Structural changes of the trabecular meshwork in different kinds of glaucoma. Exp Eye Res 88:769–775. https://doi.org/10.1016/j.exer.2008.11.025
Allingham RR, de Kater AW, Ethier CR (1996) Schlemm’s canal and primary open angle glaucoma: correlation between Schlemm’s canal dimensions and outflow facility. Exp Eye Res 62:101–110. https://doi.org/10.1006/exer.1996.0012
Andrés-Guerrero V, García-Feijoo J, Konstas AG (2017) Targeting Schlemm’s Canal in the medical therapy of glaucoma: current and future considerations. Adv Ther 34:1049–1069. https://doi.org/10.1007/s12325-017-0513-z
Gong H, Gorantla V, Zhang Y, et al (2015) Morphological changes in the distal outflow pathway of primary open angle glaucoma. In: Annual Meeting of the Association for Research in Vision and Ophthalmology
Stegmann R, Pienaar A, Miller D (1999) Viscocanalostomy for open-angle glaucoma in black African patients. J Cataract Refract Surg 25:316–322. https://doi.org/10.1016/S0886-3350(99)80078-9
Koerber N (2007) Canaloplasty-A new approach to nonpenetrating glaucoma surgery. Tech Ophthalmol 5:102–106. https://doi.org/10.1097/ITO.0b013e3181565083
Lewis RA, von Wolff K, Tetz M et al (2011) Canaloplasty: three-year results of circumferential viscodilation and tensioning of Schlemm canal using a microcatheter to treat open-angle glaucoma. J Cataract Refract Surg 37:682–690. https://doi.org/10.1016/j.jcrs.2010.10.055
Hughes T, Traynor M (2020) Clinical results of Ab interno canaloplasty in patients with open-angle glaucoma. Clin Ophthalmol 14:3641–3650. https://doi.org/10.2147/OPTH.S275087
Gallardo MJ (2021) 24-month efficacy of viscodilation of Schlemm’s canal and the distal outflow system with iTrack Ab-interno canaloplasty for the treatment of primary open-angle glaucoma. Clin Ophthalmol 15:1591–1599. https://doi.org/10.2147/OPTH.S272506
Khaimi MA (2021) Long-term medication reduction in controlled glaucoma with iTrack ab-interno canaloplasty as a standalone procedure and combined with cataract surgery. Ther Adv Ophthalmol 13:251584142110457. https://doi.org/10.1177/25158414211045751
Koerber NJ, Ondrejka S (2022) 4-Year Efficacy and Safety of iTrack Ab-interno Canaloplasty as a Standalone Procedure and Combined with Cataract Surgery in Open-Angle Glaucoma. Klin Monbl Augenheilk. Online ahead of print. https://doi.org/10.1055/a-1737-4149
Kazerounian S, Zimbelmann M, Lörtscher M et al (2020) Canaloplasty ab interno (AbiC) – 2-Year-results of a novel minimally invasive glaucoma surgery (migs) technique. Klin Monbl Augenheilk. https://doi.org/10.1055/a-1250-8431
Gillmann K, Aref A, Niegowski LJ, Baumgartner J-M (2021) Combined Ab interno viscocanaloplasty (ABiC) in open-angle glaucoma: 12-month outcomes. Int Ophthalmol 41:3295–3301. https://doi.org/10.1007/s10792-021-01891-1
Gallardo MJ, Supnet RA, Ahmed IIK (2018) Viscodilation of Schlemm’s canal for the reduction of IOP via an ab-interno approach. Clin Ophthalmol 12:2149–2155. https://doi.org/10.2147/OPTH.S177597
Koerber N (2017) Canaloplasty ab interno - a minimally invasive alternative. Klin Monbl Augenheilkd 234:991–995. https://doi.org/10.1055/s-0042-123829
Gallardo MJ, Supnet RA, Ahmed IIK (2018) Circumferential viscodilation of Schlemm’s canal for open-angle glaucoma: ab-interno vs ab-externo canaloplasty with tensioning suture. Clin Ophthalmol 12:2493–2498. https://doi.org/10.2147/OPTH.S178962
Gallardo MJ (2022) 36-month effectiveness of ab-interno canaloplasty standalone versus combined with cataract surgery for the treatment of open-angle glaucoma. Ophthalmol Glaucoma. https://doi.org/10.1016/j.ogla.2022.02.007
Lavia C, Dallorto L, Maule M et al (2017) Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: a systematic review and meta-analysis. PLoS ONE 12:e0183142. https://doi.org/10.1371/journal.pone.0183142
Rosdahl JA, Gupta D (2020) Prospective studies of minimally invasive glaucoma surgeries: systematic review and quality assessment. Clin Ophthalmol 14:231–243. https://doi.org/10.2147/OPTH.S239772
Majstruk L, Leray B, Bouillot A et al (2019) Long term effect of phacoemulsification on intraocular pressure in patients with medically controlled primary open-angle glaucoma. BMC Ophthalmol 19:1–7. https://doi.org/10.1186/S12886-019-1157-3
Shingleton BJ, Pasternack JJ, Hung JW et al (2006) Three and five year changes in intraocular pressures after clear corneal phacoemulsification in open angle glaucoma patients, glaucoma suspects, and normal patients. J Glaucoma 15:494–498. https://doi.org/10.1097/01.ijg.0000212294.31411.92
Mathalone N, Hyams M, Neiman S et al (2005) Long-term intraocular pressure control after clear corneal phacoemulsification in glaucoma patients. J Cataract Refract Surg 31:479–483. https://doi.org/10.1016/j.jcrs.2004.06.046
Fingeret M, Dickerson JE (2018) The role of minimally invasive glaucoma surgery devices in the management of glaucoma. Optom Vis Sci 95:155–162. https://doi.org/10.1097/OPX.0000000000001173
Wang B, Leng X, An X et al (2020) XEN gel implant with or without phacoemulsification for glaucoma a systematic review and meta-analysis. Ann Trans Med 8:1309–1309. https://doi.org/10.21037/atm-20-6354
Yook E, Vinod K, Panarelli JF (2018) Complications of micro-invasive glaucoma surgery. Curr Opin Ophthalmol 29:147–154. https://doi.org/10.1097/ICU.0000000000000457
Funding
The authors have no financial or proprietary interest in any material or method mentioned. The author (NK) is the Principal Investigator for the Catalyst clinical study which uses the product mentioned in this manuscript (iTrack, Nova Eye Medical).
Author information
Authors and Affiliations
Contributions
The authors have performed all the research, data analysis, manuscript writing (drafts and revisions).
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Koerber, N., Ondrejka, S. Clinical outcomes of canaloplasty via an ab-interno surgical technique using the iTrack device: a narrative review. Int Ophthalmol 43, 2017–2027 (2023). https://doi.org/10.1007/s10792-022-02601-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10792-022-02601-1